CaenenRx
Board
1 director, since incorporationDirector
since 08-01-2025
term without a fixed end
listed in the 2025 annual accounts, filed on 17-08-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 10-01-2025
Mandates through the years
2 names, the dashed line is todayDirector
Successor director
BoardEarlierend not dated
Mandates as a list
-
- Director, from 08-01-2025 to date
-
- Successor director, appointed by deed of 10-01-2025, no longer listed in the 2025 annual accounts
Control
Founder
This company
CaenenRx
Equity €29,851
Profit €27,684 in 2025
Capital
- Contribution
- €3,000
- Shares
- 1,000
- Contribution per share
- €3
- Equity per share
- €29.85 in 2025
- Source
- deed of 10-01-2025
Articles of association
deed of 10-01-2025 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- 1 director
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Na aftrek aandelen waarvan overdracht voorgesteld, helft overdrager,helft koper(s) naar evenredigheid aantal bij meer kopers”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Saturday of June at 11:00
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
- No statutory auditor
Shareholders
At incorporation
deed of 10-01-2025 ↗
- 1,000 shares (100%) · €3,000